Glenview Capital Management

Glenview Capital Management

Larry Robbins launched Glenview Capital Management in 2000 after a stint at Omega Advisors, where he covered healthcare stocks. The firm started as a long/short equity shop and rapidly gained scale by delivering concentrated bets in healthcare and other sectors. Glenview invests predominantly in public equities across healthcare, consumer, financials, technology, and energy. The firm runs a concentrated portfolio — typically 15-25 positions in its flagship fund — and uses fundamental research to identify mispriced securities. Known holdings have included Tenet Healthcare, HCA Healthcare, and UnitedHealth Group (per SEC filings, various years). Geographic exposure is primarily US, with selective positions in Europe and Asia. The firm structures investments through a master-feeder onshore/offshore vehicle and offers separately managed accounts for certain institutional clients. With around $8.5B in assets under management (Altss estimate), Glenview operates from offices in New York, Dallas, Greenwich, and Pittsburgh. The firm reduced AUM significantly from its 2014 peak of roughly $15B (per Bloomberg, 2014), returning external capital to focus on higher-conviction positions. In 2023, Glenview announced a succession plan to transition leadership to a team of younger portfolio managers, signaling a generational shift (per Bloomberg, 2023). Glenview's structural distinction lies in its concentrated healthcare focus — an edge Robbins built from two decades of sector specialization. The firm's roughly 50 professionals operate with lean overhead, avoiding the asset-gathering model that drove peers. Its succession playbook, moving to a team-based investment committee, is a rare explicit hand-off in a fund world dominated by founder-led shops.